FDA issued a Warning Letter to Tomita Pharmaceutical Co., Ltd on 1/14/2008 for a previous inspection.
483 Tomita Pharmaceutical Mar 2018

483 Tomita Pharmaceutical Mar 2018

Jason Caballero FDA, Vioela Caze FDA$119.00 - Available Now

FDA investigators audited the Tomita Pharmaceutical - Naruto, Japan facility and issued inspectional observations (via FDA 483) on 09 Mar 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Mar 2018
  • Location: Naruto, Japan
  • FEI: 3002808375
Add To Cart